持续至中晚孕期的剖宫产瘢痕妊娠不良结局:系统综述与Meta分析
该系统综述与Meta分析检索多个数据库至2025年2月12日,纳入20项研究(432例)分析持续≥14周的剖宫产瘢痕妊娠(CSP)。胎盘植入谱系疾病(PAS)和子宫切除的合并发生率分别为0.90(95%CI 0.81–0.96)和0.39(95%CI 0.22–0.57),III型和外生型CSP不良结局风险更高。
要点
- 持续至中晚孕期的CSP中,PAS合并发生率为0.90,子宫切除为0.39。
- III型和外生型CSP的侵入性PAS、子宫切除和早产风险显著高于I/II型和内生型。
- 残余肌层厚度(RMT)降低与总体PAS和侵入性PAS风险增加显著相关,并可预测子宫切除。
核心结论
- III型和外生型CSP进展至中晚孕期时PAS和子宫切除风险高,足月分娩可能性低。
- I型、II型和内生型CSP的不良结局风险相对较低。
- CSP分型和RMT是风险分层和个体化咨询的关键决定因素。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、EMBASE、Cochrane Library、ClinicalTrials.gov、中国知网和Yiigle数据库,自建库至2025年2月12日。
- 纳入报告单胎CSP持续≥14周孕妇的PAS和/或子宫切除率的研究。
- 系统综述纳入61项研究,其中20项研究(432例)纳入Meta分析。
主要发现
- PAS的合并发生率为0.90(95%CI 0.81–0.96),子宫切除的合并发生率为0.39(95%CI 0.22–0.57)。
- III型和外生型CSP分别较I/II型和内生型CSP的侵入性PAS、子宫切除和早产风险显著更高。
- RMT降低与总体PAS和侵入性PAS风险增加显著相关,并在ROC曲线分析中可预测子宫切除。
- 达到≥28周的合并发生率为0.85(95%CI 0.73–0.94),达到足月(≥37周)的合并发生率为0.19(95%CI 0.10–0.30)。
- 在报告子宫破裂的研究中,该结局的合并发生率为0.05(95%CI 0.02–0.10)。
关键数值与推荐
- CSP亚型分组:I型 vs II型 vs III型;内生型 vs 外生型。
- RMT分组:≤3 mm vs >3 mm。
临床怎么用
- CSP分型和RMT可用于风险分层和个体化咨询。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「局限性」,故未列出该栏;全文请点「阅读原文」。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Objective To review systematically and assess quantitatively the incidence and risk of placenta accreta spectrum (PAS) disorders and hysterectomy in Cesarean scar pregnancy (CSP) continuing into mid-to-late gestation. Methods A comprehensive literature search was performed in PubMed, EMBASE, Cochrane Library, ClinicalTrials.gov, China National Knowledge Infrastructure (CNKI) and Yiigle databases from inception to 12 February 2025. Studies reporting the rates of PAS and/or hysterectomy in women with a singleton CSP that continued ≥ 14 weeks' gestation were eligible for inclusion. Data extracted included information on medical history, CSP classification and clinical manifestation, gestational age at delivery and pregnancy outcome. Data were synthesized as pooled incidences and odds ratios with 95% CIs, and random-effects models were used owing to high heterogeneity. Subgroup analyses were performed according to CSP subtype (Type I vs Type II vs Type III; and endogenous vs exogenous) and residual myometrial thickness (RMT) (≤ 3 mm vs > 3 mm). Results Among 61 studies included in the systematic review, 20 studies (432 cases) were eligible for inclusion in the meta-analysis. Qualitative synthesis captured severe clinical phenotypes, including spontaneous uterine rupture and massive hemorrhage during Cesarean section. The pooled incidences of PAS and hysterectomy were 0.90 (95% CI, 0.81–0.96) and 0.39 (95% CI, 0.22–0.57), respectively. Marked heterogeneity was observed across CSP subtypes: Type-III and exogenous CSPs were associated with significantly higher odds of invasive PAS, hysterectomy and preterm delivery compared with Types-I/II and endogenous subtypes, respectively. Reduced RMT was associated significantly with increased odds of overall PAS and invasive PAS, and was predictive of hysterectomy on receiver-operating-characteristics-curve analysis. The pooled incidence of reaching ≥ 28 weeks’ gestation was 0.85 (95% CI, 0.73–0.94), whereas the pooled incidence of reaching term (≥ 37 weeks) was 0.19 (95% CI, 0.10–0.30). Among studies that reported uterine rupture, the pooled incidence of this outcome was 0.05 (95% CI, 0.02–0.10). Conclusions Type-III and exogenous CSPs that progress into mid-to-late gestation present substantial risks for PAS and hysterectomy, with a low likelihood of term delivery. Type-I, Type-II and endogenous CSPs are associated with a comparatively lower risk of adverse outcome. CSP subtype and RMT are key determinants for risk stratification and individualized counseling. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Ultrasound in Obstetrics and Gynecology:Adverse outcome in Cesarean scar pregnancy continuing into mid‐to‐late gestation: systematic review and meta‐analysis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。